Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
ObjectiveThe aim of our study is to determine clinical factors and sonographic findings associated with endometrial hyperplasia or cancer (EH+) in premenopausal and perimenopausal women. MethodsA total of 14,340 transvaginal ultrasonography examinations of 9,888 healthy premenopausal and perimenopausal women were included in this retrospective study. One hundred sixty-two subjects underwent endometrial biopsy based on abnormal uterine bleeding (AUB), sonographic endometrial abnormalities (thickened endometrium, endometrial mass, or endometrial stripe abnormality), or both. The clinical factors and sonographic endometrial abnormalities were evaluated with regard to EH+. ResultsHistologically verified EH+ was found in fourteen subjects (8.6%); ten cases of endometrial hyperplasia (EH) without atypia, three cases of EH with atypia (AEH), and one case of endometrial cancer. Neither clinical factors nor AUB were associated with EH+ (P=0.32) or AEH+ (P=0.72). Of sonographic findings, endometrial stripe abnormality was significantly associated with EH+ (P=0.003) and marginally associated with AEH+ (P=0.05), but a thickened endometrium was not associated with EH+ (P=0.43). ConclusionEndometrial stripe abnormality is a significant factor to predict EH+ in healthy premenopausal and perimenopausal women with and without AUB. However, simple measurement of endometrial thickness has a limited role in this capacity.
Abstract
ObjectiveThe aim of our study is to determine clinical factors and sonographic findings associated with endometrial hyperplasia or cancer (EH+) in premenopausal and perimenopausal women. MethodsA total of 14,340 transvaginal ultrasonography examinations of 9,888 healthy premenopausal and perimenopausal women were included in this retrospective study. One hundred sixty-two subjects underwent endometrial biopsy based on abnormal uterine bleeding (AUB), sonographic endometrial abnormalities (thickened endometrium, endometrial mass, or endometrial stripe abnormality), or both. The clinical factors and sonographic endometrial abnormalities were evaluated with regard to EH+. ResultsHistologically verified EH+ was found in fourteen subjects (8.6%); ten cases of endometrial hyperplasia (EH) without atypia, three cases of EH with atypia (AEH), and one case of endometrial cancer. Neither clinical factors nor AUB were associated with EH+ (P=0.32) or AEH+ (P=0.72). Of sonographic findings, endometrial stripe abnormality was significantly associated with EH+ (P=0.003) and marginally associated with AEH+ (P=0.05), but a thickened endometrium was not associated with EH+ (P=0.43). ConclusionEndometrial stripe abnormality is a significant factor to predict EH+ in healthy premenopausal and perimenopausal women with and without AUB. However, simple measurement of endometrial thickness has a limited role in this capacity.
참고문헌 (33)
- Brenner PF, "Differential diagnosis of abnormal uterine bleeding", Am J Obstet Gynecol, 175(3 Pt 2), pp.766~769 (1996)
- Goldstein SR, "Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding", Am J Obstet Gynecol, 177, pp.102~108 (1997)
- Astrup K, "Menstrual bleeding patterns in pre-and perimenopausal women : a population-based prospective diary study", Acta Obstet Gynecol Scand, 83, pp.197~202 (2004)
- Hallberg L, "Menstrual blood loss: a population study. Variation at different ages and attempts to define normality", Acta Obstet Gynecol Scand, 45, pp.320~351 (1966)
- Ash SJ, "Endometrial biopsy in DUB", J Reprod Med, 41, pp.892~896 (1996)
- Bray F, "Endometrial cancer incidence trends in Europe : underlying determinants and prospects for prevention", Cancer Epidemiol Biomarkers Prev, 14, pp.1132~1142 (2005)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality and Survival in 2005", Journal of Korean Medical Science, 24(6), pp.995~1003 (2009), 대한의학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회[DOI]
- Siegel R, "Cancer statistics, 2013", CA Cancer J Clin, 63, pp.11~30 (2013)
- Dreisler E, "Value of endometrial thickness measurement for diagnosing focal intrauterine pathology in women without abnormal uterine bleeding", Ultrasound Obstet Gynecol, 33, pp.344~348 (2009)
- Dubinsky TJ, "Value of sonography in the diagnosis of abnormal vaginal bleeding", J Clin Ultrasound, 32, pp.348~353 (2004)
- Gupta JK, "Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding : a meta-analysis", Acta Obstet Gynecol Scand, 81, pp.799~816 (2002)
- Getpook C, "Endometrial thickness screening in premenopausal women with abnormal uterine bleeding", J Obstet Gynaecol Res, 32, pp.588~592 (2006)
- Karlsson B, "Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding : a Nordic multicenter study", Am J Obstet Gynecol, 172, pp.1488~1494 (1995)
- Jacobs I, "Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women : a case-control study within the UKCTOCS cohort", Lancet Oncol, 12, pp.38~48 (2011)
- Smith-Bindman R, "Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities", JAMA, 280, pp.1510~1517 (1998)
- Breitkopf DM, "Detection of benign endometrial masses by endometrial stripe measurement in premenopausal women", Obstet Gynecol, 104, pp.120~125 (2004)
- Bredella MA, "Measurement of endometrial thickness at US in multicenter drug trials : value of central quality assurance reading", Radiology, 217, pp.516~520 (2000)
- Carey WD, "Cleveland Clinic Foundation. Current clinical medicine" (2010), Saunders Elsevier
- Smith RP, "Clinical management of abnormal uterine bleeding", Association of Professors of Gynecology and Obstetrics, ~ (2006)
- "The Asia-Pacific perspective: redefining obesity and its treatment" (2000)[URL]
- Kimura T, "Abnormal uterine bleeding and prognosis of endometrial cancer", Int J Gynaecol Obstet, 85, pp.145~150 (2004)
- "SEER stat fact sheets: endometrial cancer"[URL]
- Ozdemir S, "Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding", Arch Gynecol Obstet, 282, pp.395~399 (2010)
- Seebacher V, "The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer : a retrospective multi-center study", BMC Cancer, 9, pp.460~ (2009)
- Geller SE, "Differences in menstrual bleeding characteristics, functional status, and attitudes toward menstruation in three groups of women", J Womens Health Gend Based Med, 8, pp.533~540 (1999)
- Warner PE, "Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data", Am J Obstet Gynecol, 190, pp.1216~1223 (2004)
- Geller SE, "The decision-making process for the treatment of abnormal uterine bleeding", J Womens Health, 6, pp.559~567 (1997)
- Fraser IS, "Abnormal uterine bleeding : getting our terminology straight", Curr Opin Obstet Gynecol, 19, pp.591~595 (2007)
- Torres ML, "Risk factors for developing endometrial cancer after benign endometrial sampling", Obstet Gynecol, 120, pp.998~1004 (2012)
- Maxwell GL, "Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk", Gynecol Oncol, 103, pp.535~540 (2006)
- Ueland FR, "Preoperative differentiation of malignant from benign ovarian tumors : the efficacy of morphology indexing and Doppler flow sonography", Gynecol Oncol, 91, pp.46~50 (2003)
- Kaijser J, "Improving strategies for diagnosing ovarian cancer : a summary of the International Ovarian Tumor Analysis(IOTA)studies", Obstet Gynecol, 41, pp.9~20 (2013)